Your new experience awaits. Try the new design now and help us make it even better

CASE REPORT article

Front. Hum. Neurosci., 10 October 2025

Sec. Brain Health and Clinical Neuroscience

Volume 19 - 2025 | https://doi.org/10.3389/fnhum.2025.1618266

This article is part of the Research TopicAdvances in epilepsy research: exploring biomarkers, brain stimulation, and neurosurgical interventions - Volume IIView all articles

Efficacy of snap-needle patch therapy in pediatric epilepsy: a case study


Jia ShiJia Shi1Yu GongYu Gong2Yuanyuan DengYuanyuan Deng1Zhen MaZhen Ma1ZiChun XiaoZiChun Xiao2HanYing TanHanYing Tan1WeiLan Qin*WeiLan Qin1*
  • 1The Second Clinical Hospital of Beijing, University of Chinese Medicine, Beijing, China
  • 2School of Acupuncture and Moxibustion, Beijing University of Chinese Medicine, Beijing, China

Backgrounds: Epilepsy is a prevalent neurological disorder in early childhood, often characterized by genetic predisposition and diverse clinical manifestations. Benign epilepsy of childhood with central temporal spikes (BECTS) is the most common form of self-limited focal epilepsy (SeLFE) syndrome in children, accounting for approximately 6%–7% of all childhood epilepsy cases (Wirrell et al., 2011; Camfield et al., 1996). We report a case of a child who was treated with additional snap-needle for 3 months on top of poorly controlled oral medication alone, who stopped having seizures and gradually reduced the dose of oral medication and finally stopped, and was followed up for 1 year after stopping the medication without any recurrence.

Case summary: A 10-years-old male had his first generalized tonic-clonic seizure (GTCS) at age 7 during nocturnal sleep. Following this event, the parents sought medical evaluation, and an electroencephalogram (EEG) showed abnormal wave patterns. Over the following 3 years, the child had 2–3 GTCS annually; despite multiple adjustments to antiepileptic drug (AED) therapy, GTCS frequency indicated disease progression. However, after starting snap-needle patch therapy [guided by Traditional Chinese Medicine (TCM) principles], the child remained seizure-free. Continuous monitoring has been conducted to date. We present this case of a pediatric patient with epilepsy: oral medication failed to control GTCS, but snap-needle patch therapy achieved successful seizure management, after which oral medication was discontinued.

Conclusion: After a systematic literature search, this study represents the first case report of BECTS treated with snap-needle therapy (needle size: 0.220 mm × 1.5 mm). In this case, the child’s GTCSs resolved following the addition of snap-needle therapy, and oral antiepileptic medication was gradually reduced to complete discontinuation; no seizure recurrence was observed within 1 year of follow-up. It is important to acknowledge that the contributions of medication adjustments and the self-limiting nature of BECTS cannot be ruled out in this case. However, based on the observations here, we propose the hypothesis that snap-needle intervention is likely associated with seizure remission. Although the mechanism underlying snap-needle therapy for BECTS remains unclear, the child achieved a QOLCE-16-C score of 98.4 at the end of treatment; during the 1-year follow-up, the number of nighttime sleep disruptions also decreased from 2 to 5 episodes per year to 0. These outcomes surpass those typically achievable through pharmacological intervention alone.

1 Introduction

Epilepsy is a prevalent neurological disorder characterized by an abnormal imbalance between excitatory and inhibitory activities within neuronal networks (Fisher et al., 2005). Self-limited focal epilepsy (SeLFE) syndrome constitutes approximately 25% of all pediatric epilepsy cases (Panayiotopoulos et al., 2008). Benign epilepsy of childhood with central temporal spikes (BECTS) represents the most prevalent form of SeLFE, constituting approximately 6%–7% of all pediatric epilepsy cases (Wirrell et al., 2011; Camfield et al., 1996). BECTS typically manifests in early school-aged children (Loiseau and Beaussart, 1973), and may have a hereditary component (Pal et al., 2016; Vears et al., 2012).

Current therapeutic strategies for epilepsy primarily involve pharmacological agents that modulate ion channels or neurotransmitter systems to achieve clinical efficacy (Rogawski et al., 2016). Sodium channel blockers, such as levetiracetam, phenobarbital, and phenytoin sodium, are considered first-line treatments (Rogawski et al., 2016). In cases of persistent status epilepticus unresponsive to oral medications, intravenous administration of benzodiazepines or anesthetics may be warranted (Loiseau and Beaussart, 1973). Nonetheless, certain medications, including barbiturates, may pose long-term detrimental effects on the developing brain (Borowicz-Reutt et al., 2023). Despite the administration of oral or intravenous medications, 37% of patients do not experience relief (Brodie and Dichter, 1996). Patients who exhibit an inadequate response to initial antiepileptic drug (AED) treatment are at a heightened risk of developing refractory epilepsy (Kwan and Brodie, 2000). Childhood and adolescence represent critical periods for bone development, and individuals undergoing long-term AED therapy (or initiating such therapy), demonstrate increased rates of bone loss (Pack, 2008). The developing brains of children are particularly susceptible to the sedative and anticholinergic neurological effects of antiepileptic drugs; When used as part of a multidrug combination therapy, these effects may exacerbate cognitive decline (Jankovic and Dostic, 2012) thereby impairing normal neurodevelopment in pediatric populations.

Amidst ongoing efforts to advance medical treatments, snap-needle therapy, a novel acupuncture technique rooted in traditional Chinese medicine (TCM), is gaining attention in modern clinical practice. Unlike traditional acupuncture, snap-needle therapy involves the superficial insertion of needles at acupuncture points, which are retained for extended durations. This approach minimizes disruption to daily activities while providing continuous acupoint stimulation. For epilepsy management, snap needles for epilepsy are utilized to stimulate acupuncture points, thereby exerting a distal therapeutic effect. Specifically, the stimulation of acupuncture points via snap needles activates sensory neurons, which subsequently interact with the central nervous system (Magnusson et al., 1994). This interaction triggers physiological pathways that regulate both the brain and peripheral systems. Derived from The Yellow Emperor’s Classic of Internal Medicine this microneedling technique is increasingly recognized for its unique therapeutic potential within the context of modern neuroscience.

A systematic literature search confirmed this is the first case report of BECTS treated with snap-needle therapy (needle size: 0.220 mm × 1.5 mm); no similar studies with this therapy and indication were identified.

2 Case presentation

2.1 Case presentation

A 10-years-old male patient was referred to our hospital by his parents due to the onset of generalized tonic-clonic seizure (GTCS) at the age of 7, occurring with a frequency of 2–3 episodes annually. The patient’s family history reveals potential genetic predispositions. He has a half-sister who experienced two febrile convulsions at the age of 5, which did not recur, and she is currently developing normally. The patient’s father experienced one GTCS during childhood, which was neither clearly diagnosed nor treated. The patient was born at 34 weeks of gestation via uncomplicated vaginal delivery, with a birth weight of 3,000 g. His developmental milestones were achieved within normal limits, including head control at 4 months, independent walking and single-word speech at 1 year, and short sentence formation at 2 years; his (developmental quotient, DQ) was 88 at 5 years.

At the age of 7, the patient began experiencing generalized tonic-clonic seizures (GTCSs) characterized by the following symptoms: approximately 30 min into nocturnal sleep, the patient exhibited sudden limb extension and tension, deviation of the mouth corners to the left, salivary frothing, and upward squinting of the eyes toward the left. This was followed by bilateral upper limb convulsions and an unresponsiveness to family members’ prompts, with the episode lasting over 10 min. Postictal symptoms included mild breath-holding, which gradually subsided, and the patient’s mental status returned to baseline. The initial GTCS occurred without a preexisting fever. Over the subsequent 6 days, the patient experienced 2 additional GTCSs of a similar nature. These episodes were closely associated with sleep-wake transition period.

The patient and his parents presented to the Department of Neurology at a pediatric hospital, where the patient underwent electroencephalogram (EEG) monitoring and brain magnetic resonance imaging (MRI). The MRI results did not reveal any significant abnormalities. However, based on the EEG findings and clinical manifestations, the child was diagnosed with BECTS and initiated on levetiracetam tablets for epilepsy management. The prescribed dosage was 0.375 g orally in the morning and 0.5 g orally in the evening.

Between the ages of 8 and 9, the patient experienced 3 and 2 GTCSs, respectively. These episodes occurred approximately 15 min after falling asleep and were characterized by upward-leftward eye deviation, mild salivation with mouth opening, and subsequent generalized limb convulsions lasting ∼3 min. Postictal recovery was uneventful, with the patient returning to a normal state of consciousness and reporting no discomfort. During this period, the patient’s EEG was conducted at a pediatric hospital, leading to an adjustment in the levetiracetam dosage to 0.75 g in the morning and 1 g in the evening.

At the age of 10, the patient experienced two consecutive generalized tonic-clonic seizures (GTCSs) on the 2 days preceding the consultation. These episodes were characterized by upward-leftward eye deviation, mouth opening, and mild salivation approximately 10 min after falling asleep. This was followed by marked limb convulsions and a temporary unresponsiveness to familial prompts. Each episode lasted ∼ 10 min and resolved spontaneously, and was followed by the patient’s return to baseline mental status.

2.2 Clinical examination

On physical examination, the 10-years-old male patient had a height of 141 cm, weight of 51 kg, and body mass index (BMI) of 25.7 kg/m2. His motor development was generally normal, speech was intact, and intellectual development was within normal limits, although he ranked in the lower-middle of his class academically.

2.3 Electroencephalogram

Prior to treatment, the male patient, was admitted to a pediatric hospital where he underwent an EEG examination. The EEG findings indicated abnormal waveforms characterized by asynchrony and frequent occurrences of spikes, polyspikes, sharp waves, and diffuse waves. These anomalies were predominantly observed in the bilateral central and parietal regions, as well as the middle and posterior temporal leads. They had the potential to propagate to adjacent leads during all stages of wakefulness and sleep. Notably, the pathological waveforms were more pronounced during the sleep phase. The EEG background activity was considered abnormal, with complete suppression of alpha waves when the patient was awake, regardless of whether his eyes were open or closed. Pathological waves were also detected during hyperventilation, although flash stimulation was not performed. During sleep, symmetrical bilateral wave crests and hammer waves were observed. The right central, parietal, and temporal regions exhibited medium to high amplitude spiking, spiking slow waves, and polyspiking waves, which could spread to other leads, with the central temporal lead being the most affected (Figure 1).

FIGURE 1
EEG tracings split into three sections labeled A, B, and C. Section A shows slow, high-amplitude waves with an arrow marked. Section B, labeled “sleep,” displays faster frequency waves, also with arrows. Section C, labeled “awake,” shows mixed-frequency waves with several arrows pointing to specific features. Settings at the bottom include paper speed and sensitivity.

Figure 1. Electroencephalogram (EEG). (A) High-amplitude sharp and slow waves are observed in the central-temporal region (Rolandic waves). (B,C) Medium to high amplitude sharp waves, spike waves, spike-slow waves, and polyspike waves are frequently detected in the primary leads, predominantly in the right central, parietal, and temporal regions, with potential propagation to other leads (closely related to the sleep-wake transition).

2.4 Diagnosis, treatment, and follow-up

Considering the patient’s history, symptoms, and EEG findings, an acupuncturist with 19 years of clinical experience prescribed a 3-month course of snap-needle treatment. The selected acupuncture points included the DU14, BL13, DU11, BL18, DU8, DU6 (Figure 2 and Table 1). Snap-needle stimulation facilitates the propagation of electrical signals generated at these points along the afferent nerve fibers, which then travel through the dorsal roots into the spinal cord sensory signals are transmitted to the central nervous system via the spinothalamic tracts and the dorsal column-medial lemniscal pathway. The thalamus functions acts as a relay station, facilitating the processing and integration of these signals into various regions, including the somatosensory cortex, insula, cingulate cortex, and limbic system, thereby triggering neurotransmitter release and modulating neural activity (Zhang et al., 2014). In the snap-needle treatment procedure, a single-use sterile snap-needle is selected (Figure 2). Initially, the local skin on the patient’s back is disinfected. The snap-needle is then aligned with the designated acupoint and pressed for 30 s at per acupoint. The snap-needle remains in place for 24 h, during which the patient’s parents are instructed to apply pressure to the points three times daily (at 09:00, 16:00, and 20:00) for 30 s each time. The patient is instructed to avoid exposing the snap-needle site to liquids and to refrain from water contact for 4 h after snap-needle removal minimizing the risk of infection. The acupoint locations are illustrated in the accompanying figure. Snap-needle therapy is administered weekly; the same acupoints or areas are not always reused during a 3-months period. Treatment points are adjusted promptly based on the patient’s condition. The specific selection of acupoints is shown in Figure 2 and Table 1.

FIGURE 2
A: A child’s back with six marked acupuncture points highlighted by red and grey circles and numbered lines. B: Packaging labeled in Chinese and English, reading “Cloud & Dragon Medical Device Co., Ltd.” with “press needles” indicated. C: Close-up of a transparent plastic case containing acupuncture press needles, with one needle sheet partially removed.

Figure 2. (A) The specified positions and the pressing needles utilized. (Apply ➀ + ➂ + ➄ + ➅ + ➁ / ➃ (bilaterally) at each point, where ➁ and ➃ are applied alternately each time. (B) Packaging labeled in Chinese and English, reading “Cloud & Dragon Medical Device Co., Ltd.” with “press needles” indicated. (C) Close-up of a transparent plastic case containing acupuncture press needles, with one needle sheet partially removed.

TABLE 1
www.frontiersin.org

Table 1. Location/channel distribution/procedure.

Following treatment, the child’s condition stabilized, allowing for a gradual reduction in the dosage of levetiracetam tablets in collaboration with the neurology department. During follow-up until March 2025, the boy did not experience any further GTCSs. Meanwhile, parent interviews showed the child achieved a score of 98.4 on the Chinese version of the QOLCE-16-C quality of life scale (Tang et al., 2022) post-treatment. After 1 year of follow-up, parent reports showed the child’s daily function improved: nighttime sleep interruptions decreased from 3 to 0 per year; parents and teachers noted more stable emotions, independent homework completion (pre-intervention required full parental assistance), and increased peer interaction frequency from 1–2 to 5–6 times per day (per school teacher observation records). These findings indicate good recovery in the child (Figure 3 and Table 2).

FIGURE 3
Line graph showing the number of seizures from October 2020 to March 2025. Seizures increase from 1 to 3 by October 2021, then decrease steadily to 0 by November 2023. Key events include initiating snap-needle therapy in July 2023 and discontinuing it in October 2023, resulting in seizure reduction. Medication adjustments are noted alongside.

Figure 3. Line graph showing the number of seizures from October 2020 to March 2025. Seizures increase from 1 to 3 by October 2021, then decrease steadily to 0 by November 2023. Key events include initiating snap-needle therapy in July 2023 and discontinuing it in October 2023, resulting in seizure reduction. Medication adjustments are noted alongside.

TABLE 2
www.frontiersin.org

Table 2. Structured abstract of epilepsy treatment process.

3 Discussion

Benign epilepsy of childhood with central temporal spikes constitutes approximately 6%–7% of all childhood epilepsy cases (Wirrell et al., 2011), and its prognosis is generally regarded as favorable (Camfield and Camfield, 2012). Nevertheless, there is a potential risk of developing other, more refractory epilepsy syndromes (Taylor et al., 2008). BECTS exhibits familial aggregation, with relatives of individuals with BECTS showing a higher risk of epilepsy compared to control groups (Neubauer et al., 1998; De Tiège et al., 2006). Focal spikes associated with BECTS are typically activated during sleep (Camfield and Camfield, 2012), and sleep-related epileptic activity during sleep can disrupt physiological slow-wave activity (SWA). Local synapses undergo modification following sleep in the SWA steady state (Tononi and Cirelli, 2003) and performance on motor and categorization tasks improves after sleep (Fenn et al., 2003), such disruptions may impair neurons’ learning capacity (Tassinari and Rubboli, 2006). Conversely, BECTS may also cause cortical dysfunction, subsequently impairing cognitive function and hindering local plasticity changes in associated neurons (Aarts et al., 1984). Cortical regions impacted by epileptic activity in children with BECTS exhibit significant spiking, which predisposes these individuals to disturbances in frontal lobe function during childhood development. This disruption adversely affects the normal physiological processes underlying cognitive function. Consequently, children’s physical performance, intelligence quotient (IQ), memory, and executive function are notably compromised (Massa et al., 2001). At the molecular level, the presence of abundant spiking waves is attributed to the hyper-synchronized action of γ-aminobutyric acid (GABA), which inhibits the enhancement of cortical inhibition mediated by postsynaptic potentials. This heightened cortical inhibition temporarily disrupts the normal physiological processes essential for cognitive function (Massa et al., 2001), resulting in cognitive deficits in the affected child. Furthermore, previous research has indicated that a subset of BECTS patients experience neuropsychological and behavioral deficits of varying severity. The disorder also has long been associated with transient or permanent speech impairments (Scheffer et al., 1995).

In this particular case, the patient experienced initial symptom onset at the age of 7. The episodes were exclusively nocturnal, occurring during sleep (i.e., sleep-related). Prior to treatment initiation, a video EEG was performed, revealing abnormal waveforms characterized by short-range spikes, spikes and slow waves, polyspike-and-slow waves, with a pronounced presence on the right side. These abnormal discharges predominantly involved the central, middle temporal, and posterior temporal regions, with a marked increase during sleep. Brain magnetic resonance imaging (MRI) revealed no structural abnormalities. The child had no significant perinatal history, no history of febrile seizures, and no family history of epilepsy or epilepsy-related disorders. The seizure pattern showed a strong correlation with the sleep-wake cycle. Based on the combination of clinical history, symptomatology, examination findings, and family history, a diagnosis of BECTS syndrome was supported.

The patient exhibits a propensity for frequent short-term GTCSs, which have adversely impacted the child’s learning abilities and cognitive behavior, rendering them slightly below the normative levels for same-age children. These GTCSs have also significantly influenced the child’s self-confidence and psychosocial functioning. At the initial clinic visit, the child demonstrated marked low self-esteem and reluctance to interact with peers. Despite antiepileptic drug (AED) treatment, the child experienced five GTCSs prior to their initial consultation at the acupuncture department of our TCM hospital in 2023. During this period, the patient received multiple doses of levetiracetam. Suggesting that the disease remains uncontrolled and progressive. Numerous studies have demonstrated that the initial AED response and early treatment response, are strong prognostic indicators of favorable outcome (Sillanpää et al., 1998; Annegers et al., 1979; Elwes et al., 1984). This evidence suggests a higher likelihood of persistent abnormal EEG activity. Consequently, timely management of the patient’s seizure progression is of paramount importance. Failure to do so may result in the persistence of abnormal electroencephalographic activity, which could further impair the function of the corresponding cerebral cortex. This impairment may lead to abnormalities in the child’s motor skills, somatosensory processing, spatial awareness, and memory function.

In comparison to traditional acupuncture, snap needles are characterized by shorter lengths and more superficial insertion, resulting in gentler stimulation that is particularly suitable for pediatric patients. Additionally, snap-needle therapy enables prolonged treatment durations and minimizes disruption to daily activities, rendering it advantageous for conditions requiring long-term management. Basic research indicates that snap-needle application activates acupoint sensory neurons, which mediate signals to the central nervous system (Magnusson et al., 1994) and increase cortical gamma oscillations (Wu et al., 2024) -a process that may improve cognition, memory formation, and attention (Gillespie et al., 2016). However, this mechanism requires further validation via subsequent animal experiments or clinical studies. Recent neuroimaging studies has demonstrated that snap-needle stimulation of the vagus nerve distribution in the ear significantly activates the nucleus of the solitary tract (NTS) within the brainstem. This nerve impulse is subsequently transmitted through the reticular activating system to the limbic system (Frauscher et al., 2023). Current evidence suggests that snap needles establish a bioelectrical circuit via the auricular branch of the vagus nerve, and that 0.3–0.5 mA microcurrent stimulation can modulate autonomic homeostasis for up to 72 h (Percin et al., 2024). No molecular biology or electrophysiological tests (e.g., neurotransmitter level detection, intracerebral oscillatory recordings) were conducted to confirm the specific role of the aforementioned mechanism in this patient, requiring follow-up experimental verification.

Numerous mechanistic studies have demonstrated that acupoint stimulation can alleviate epilepsy by activating the vagus nerve (He et al., 2012; Cakmak, 2006), this activation subsequently stimulates the nucleus of the solitary tract (NTS) (Rhoton et al., 1966; Morest, 1967; Aghajanian and Wang, 1977; Ricardo and Koh, 1978; Saper and Loewy, 1980; Saper, 1982). This activation modulates opioid receptors in the amygdala, thereby suppressing focal epilepsy and preventing epilepsy-related sleep disturbances (Yi et al., 2015).

Regarding the selection of acupoints for epilepsy treatment, it is crucial individualize acupoint choice based on the patient’s specific condition, as different acupoints exert distinct effects on brain structural functions. This individualized approach aims to optimize therapeutic efficacy. In this case report, we used traditional acupoint localization combined with snap-needle therapy, targeting the patient’s back acupoints to reduce seizure frequency, improve the child’s learning and cognitive abilities, and potentially avoid the need for antiepileptic drug (AED) treatment. One of the primary points, DU14, is known to activate brain function and regulate cognitive function. Recent studies have shown that electroacupuncture (EA) stimulation at this point can effectively treat temporal lobe epilepsy (TLE) in rats. The underlying mechanism involves increased levels of p-ULK1/ULK1, LC3-II/LC3-I, and p62 in these rats following stimulation. Meanwhile, prior studies have shown that GV14 stimulation modulates the AKT/mTOR signaling pathway to treat epilepsy and promotes hippocampal neuron autophagy during epileptic seizures (Gao et al., 2022). The liver acupoint (BL18) primarily disperses liver wind, and previous studies have shown submerged needle stimulation of BL18 controls drug-resistant epileptic seizures (Nguyen et al., 2023). Additionally, stimulation of BL13 has been reported to enhance prefrontal learning and memory in rats, which is attributed to its role in downregulating the expression of IL-1β and TNF-α in the prefrontal cortex and hippocampus, thereby mitigating inflammatory responses (Wu et al., 2015). DU11 is frequently utilized to regulate nervous system function and demonstrates significant efficacy in treating mental disorders such as insomnia and anxiety. Earlier research indicates that stimulation of this acupoint can ameliorate sleep disorders by influencing neurotransmitter balance, specifically through the modulation of dopamine release in regions such as the nucleus ambiguous (Jin et al., 2018). DU14, DU11, DU8, and DU6 are situated along are located on the Du Meridian (adjacent to the spine). Studies have demonstrated that stimulating the Du Meridian activates adjacent spinal and sympathetic nerves, which inhibits cerebral cortical overexcitation, enhances the release of γ-aminobutyric acid (GABA, the central nervous system’s primary inhibitory neurotransmitter), and reduces abnormal neuronal discharge via nerve pathways (Linderoth et al., 1994).

4 Conclusion

In conclusion, our case study suggests that, in conjunction with medication, the use of snap needles can enhance the ability of children with epilepsy to live and learn, improve their quality of life, and, most importantly, reduce seizure frequency. Snap needles may represent an effective, cost-efficient, and safe adjunctive therapy. However, this report has notable limitations. First, despite the progressive reduction in oral levetiracetam dosage, the confounding effect of this medication on seizure remission cannot be fully excluded. Second, while snap-needle therapy may have shortened the child’s BECTS duration, spontaneous resolution–consistent with BECTS’ self-limiting nature–remains a possibility. Thus, this report only puts forward a hypothesis based on a single case: snap-needle intervention may be associated with BECTS seizure remission. Subsequent studies should eliminate drug confounders, include EEG findings as a core outcome measure, and adopt larger sample sizes to systematically evaluate the therapy’s effectiveness.

Data availability statement

The original contributions presented in this study are included in this article/supplementary material, further inquiries can be directed to the corresponding author.

Ethics statement

Written informed consent was obtained from the individual(s), and minor(s)’ legal guardian/next of kin, for the publication of any potentially identifiable images or data included in this article. Written informed consent was obtained from the participant/patient(s) for the publication of this case report.

Author contributions

JS: Writing – original draft, Writing – review & editing. YG: Writing – review & editing. YD: Writing – review & editing, Visualization. ZM: Resources, Writing – review & editing. ZX: Writing – review & editing. HT: Writing – review & editing. WQ: Writing – review & editing, Funding acquisition, Resources, Supervision.

Funding

The author(s) declare that financial support was received for the research and/or publication of this article. This study was funded by the Second Affiliated Hospital of Beijing University of Traditional Chinese Medicine (Grant No. 2023-DFYY-180).

Acknowledgments

We are grateful to the patient for agreeing to publish this report.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Generative AI statement

The author(s) declare that no Generative AI was used in the creation of this manuscript.

Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Abbreviations

BECTS, benign epilepsy of childhood with central temporal spikes; SeLFE, self-limited focal epilepsy; EEG, electroencephalogram; TCM, traditional Chinese medicine; AED, antiepileptic drug; MRI, magnetic resonance imaging; SWA, slow-wave activity; IQ, intelligence quotient; GABA, γ-aminobutyric acid; GTCS, generalized tonic-clonic seizure.

References

Aarts, J. H., Binnie, C. D., Smit, A. M., and Wilkins, A. J. (1984). Selective cognitive impairment during focal and generalized epileptiform EEG activity. Brain 107(Pt 1), 293–308. doi: 10.1093/brain/107.1.293

PubMed Abstract | Crossref Full Text | Google Scholar

Aghajanian, G. K., and Wang, R. Y. (1977). Habenular and other midbrain raphe afferents demonstrated by a modified retrograde tracing technique. Brain Res. 122, 229–242. doi: 10.1016/0006-8993(77)90291-8

PubMed Abstract | Crossref Full Text | Google Scholar

Annegers, J. F., Hauser, W. A., and Elveback, L. R. (1979). Remission of seizures and relapse in patients with epilepsy. Epilepsia 20, 729–737. doi: 10.1111/j.1528-1157.1979.tb04857.x

PubMed Abstract | Crossref Full Text | Google Scholar

Borowicz-Reutt, K., Czernia, J., and Krawczyk, M. (2023). Genetic background of epilepsy and antiepileptic treatments. Int. J. Mol. Sci. 24:16280. doi: 10.3390/ijms242216280

PubMed Abstract | Crossref Full Text | Google Scholar

Brodie, M. J., and Dichter, M. A. (1996). Antiepileptic drugs. N. Engl. J. Med. 334, 168–175. doi: 10.1056/NEJM199601183340308

PubMed Abstract | Crossref Full Text | Google Scholar

Cakmak, Y. O. (2006). Epilepsy, electroacupuncture and the nucleus of the solitary tract. Acupunct. Med. 24, 164–168. doi: 10.1136/aim.24.4.164

PubMed Abstract | Crossref Full Text | Google Scholar

Camfield, C. S., Camfield, P. R., Gordon, K., Wirrell, E., and Dooley, J. M. (1996). Incidence of epilepsy in childhood and adolescence: A population-based study in Nova Scotia from 1977 to 1985. Epilepsia 37, 19–23. doi: 10.1111/j.1528-1157.1996.tb00506.x

PubMed Abstract | Crossref Full Text | Google Scholar

Camfield, P., and Camfield, C. (2012). Unprovoked status epilepticus: The prognosis for otherwise normal children with focal epilepsy. Pediatrics 130, e501–e506. doi: 10.1542/peds.2012-0838

PubMed Abstract | Crossref Full Text | Google Scholar

De Tiège, X., Goldman, S., Verheulpen, D., Aeby, A., Poznanski, N., and Van Bogaert, P. (2006). Coexistence of idiopathic rolandic epilepsy and CSWS in two families. Epilepsia 47, 1723–1727. doi: 10.1111/j.1528-1167.2006.00644.x

PubMed Abstract | Crossref Full Text | Google Scholar

Elwes, R. D., Johnson, A. L., Shorvon, S. D., and Reynolds, E. H. (1984). The prognosis for seizure control in newly diagnosed epilepsy. N. Engl. J. Med. 311, 944–947. doi: 10.1056/NEJM198410113111503

PubMed Abstract | Crossref Full Text | Google Scholar

Fenn, K. M., Nusbaum, H. C., and Margoliash, D. (2003). Consolidation during sleep of perceptual learning of spoken language. Nature 425, 614–616. doi: 10.1038/nature01951

PubMed Abstract | Crossref Full Text | Google Scholar

Fisher, R. S., van Emde Boas, W., Blume, W., Elger, C., Genton, P., Lee, P., et al. (2005). Epileptic seizures and epilepsy: Definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 46, 470–472. doi: 10.1111/j.0013-9580.2005.66104.x

PubMed Abstract | Crossref Full Text | Google Scholar

Frauscher, B., Bartolomei, F., Baud, M. O., Smith, R. J., Worrell, G., and Lundstrom, B. N. (2023). Stimulation to probe, excite, and inhibit the epileptic brain. Epilepsia 64(Suppl. 3), S49–S61. doi: 10.1111/epi.17640

PubMed Abstract | Crossref Full Text | Google Scholar

Gao, D., Ma, L., Xie, Y., Xiao, B., Xue, S., Xiao, W., et al. (2022). Electroacupuncture promotes autophagy by regulating the AKT/mTOR signaling pathway in temporal lobe epilepsy. Neurochem. Res. 47, 2396–2404. doi: 10.1007/s11064-022-03634-9

PubMed Abstract | Crossref Full Text | Google Scholar

Gillespie, A. K., Jones, E. A., Lin, Y. H., Karlsson, M. P., Kay, K., Yoon, S. Y., et al. (2016). Apolipoprotein E4 causes age-dependent disruption of slow gamma oscillations during hippocampal sharp-wave ripples. Neuron 90, 740–751. doi: 10.1016/j.neuron.2016.04.009

PubMed Abstract | Crossref Full Text | Google Scholar

He, W., Rong, P. J., Li, L., Ben, H., Zhu, B., and Litscher, G. (2012). Auricular acupuncture may suppress epileptic seizures via activating the parasympathetic nervous system: A hypothesis based on innovative methods. Evid. Based Compl. Alternat. Med. 2012:615476. doi: 10.1155/2012/615476

PubMed Abstract | Crossref Full Text | Google Scholar

Jankovic, S. M., and Dostic, M. (2012). Choice of antiepileptic drugs for the elderly: Possible drug interactions and adverse effects. Expert Opin. Drug Metab. Toxicol. 8, 81–91. doi: 10.1517/17425255.2012.645535

PubMed Abstract | Crossref Full Text | Google Scholar

Jin, W., Kim, M. S., Jang, E. Y., Lee, J. Y., Lee, J. G., Kim, H. Y., et al. (2018). Acupuncture reduces relapse to cocaine-seeking behavior via activation of GABA neurons in the ventral tegmental area. Addict. Biol. 23, 165–181. doi: 10.1111/adb.12499

PubMed Abstract | Crossref Full Text | Google Scholar

Kwan, P., and Brodie, M. J. (2000). Early identification of refractory epilepsy. N. Engl. J. Med. 342, 314–319. doi: 10.1056/NEJM200002033420503

PubMed Abstract | Crossref Full Text | Google Scholar

Linderoth, B., Stiller, C. O., Gunasekera, L., O’Connor, W. T., Ungerstedt, U., and Brodin, E. (1994). Gamma-aminobutyric acid is released in the dorsal horn by electrical spinal cord stimulation: An in vivo microdialysis study in the rat. Neurosurgery 34, 484–448; discussion 488–489. doi: 10.1227/00006123-199403000-00014

PubMed Abstract | Crossref Full Text | Google Scholar

Loiseau, P., and Beaussart, M. (1973). The seizures of benign childhood epilepsy with Rolandic paroxysmal discharges. Epilepsia 14, 381–389. doi: 10.1111/j.1528-1157.1973.tb03977.x

PubMed Abstract | Crossref Full Text | Google Scholar

Magnusson, M., Johansson, K., and Johansson, B. B. (1994). Sensory stimulation promotes normalization of postural control after stroke. Stroke 25, 1176–1180. doi: 10.1161/01.str.25.6.1176

PubMed Abstract | Crossref Full Text | Google Scholar

Massa, R., de Saint-Martin, A., Carcangiu, R., Rudolf, G., Seegmuller, C., Kleitz, C., et al. (2001). EEG criteria predictive of complicated evolution in idiopathic rolandic epilepsy. Neurology 57, 1071–1079. doi: 10.1212/wnl.57.6.1071

PubMed Abstract | Crossref Full Text | Google Scholar

Morest, D. K. (1967). Experimental study of the projections of the nucleus of the tractus solitarius and the area postrema in the cat. J. Comp. Neurol. 130, 277–300. doi: 10.1002/cne.901300402

PubMed Abstract | Crossref Full Text | Google Scholar

Neubauer, B. A., Fiedler, B., Himmelein, B., Kämpfer, F., Lässker, U., Schwabe, G., et al. (1998). Centrotemporal spikes in families with rolandic epilepsy: Linkage to chromosome 15q14. Neurology 51, 1608–1612. doi: 10.1212/wnl.51.6.1608

PubMed Abstract | Crossref Full Text | Google Scholar

Nguyen, V. D., Pham, D. T., Le, M. T., and Shen, G. M. (2023). Effect on satisfactory seizure control and heart rate variability of thread-embedding acupuncture for drug-resistant epilepsy: A patient-assessor blinded, randomized controlled trial. Behav. Neurol. 2023:5871991. doi: 10.1155/2023/5871991

PubMed Abstract | Crossref Full Text | Google Scholar

Pack, A. (2008). Bone health in people with epilepsy: Is it impaired and what are the risk factors? Seizure 17, 181–186. doi: 10.1016/j.seizure.2007.11.020

PubMed Abstract | Crossref Full Text | Google Scholar

Pal, D. K., Ferrie, C., Addis, L., Akiyama, T., Capovilla, G., Caraballo, R., et al. (2016). Idiopathic focal epilepsies: The “lost tribe”. Epileptic Disord. 18, 252–288. doi: 10.1684/epd.2016.0839

PubMed Abstract | Crossref Full Text | Google Scholar

Panayiotopoulos, C. P., Michael, M., Sanders, S., Valeta, T., and Koutroumanidis, M. (2008). Benign childhood focal epilepsies: Assessment of established and newly recognized syndromes. Brain 131(Pt 9), 2264–2286. doi: 10.1093/brain/awn162

PubMed Abstract | Crossref Full Text | Google Scholar

Percin, A., Ozden, A. V., Yenisehir, S., Pehlivanoglu, B. E., and Yılmaz, R. C. (2024). The effect of in-ear and behind-ear transcutaneous auricular vagus nerve stimulation on autonomic function: A randomized, single-blind, sham-controlled study. J. Clin. Med. 13:4385. doi: 10.3390/jcm13154385

PubMed Abstract | Crossref Full Text | Google Scholar

Rhoton, A. L., O’Leary, J. L., and Ferguson, J. P. (1966). The trigeminal, facial, vagal, and glossopharyngeal nerves in the monkey. Afferent connections. Arch. Neurol. 14, 530–540. doi: 10.1001/archneur.1966.00470110074010

PubMed Abstract | Crossref Full Text | Google Scholar

Ricardo, J. A., and Koh, E. T. (1978). Anatomical evidence of direct projections from the nucleus of the solitary tract to the hypothalamus, amygdala, and other forebrain structures in the rat. Brain Res. 153, 1–26. doi: 10.1016/0006-8993(78)91125-3

PubMed Abstract | Crossref Full Text | Google Scholar

Rogawski, M. A., Löscher, W., and Rho, J. M. (2016). Mechanisms of action of antiseizure drugs and the ketogenic diet. Cold Spring Harb. Perspect. Med. 6:a022780. doi: 10.1101/cshperspect.a022780

PubMed Abstract | Crossref Full Text | Google Scholar

Saper, C. B. (1982). Convergence of autonomic and limbic connections in the insular cortex of the rat. J. Comp. Neurol. 210, 163–173. doi: 10.1002/cne.902100207

PubMed Abstract | Crossref Full Text | Google Scholar

Saper, C. B., and Loewy, A. D. (1980). Efferent connections of the parabrachial nucleus in the rat. Brain Res. 197, 291–317. doi: 10.1016/0006-8993(80)91117-8

PubMed Abstract | Crossref Full Text | Google Scholar

Scheffer, I. E., Jones, L., Pozzebon, M., Howell, R. A., Saling, M. M., and Berkovic, S. F. (1995). Autosomal dominant rolandic epilepsy and speech dyspraxia: A new syndrome with anticipation. Ann. Neurol. 38, 633–642. doi: 10.1002/ana.410380412

PubMed Abstract | Crossref Full Text | Google Scholar

Sillanpää, M., Jalava, M., Kaleva, O., and Shinnar, S. (1998). Long-term prognosis of seizures with onset in childhood. N. Engl. J. Med. 338, 1715–1722. doi: 10.1056/NEJM199806113382402

PubMed Abstract | Crossref Full Text | Google Scholar

Tang, P., Lu, Q., Wu, Y., Wang, L., Tang, W., Jiang, Y., et al. (2022). The Chinese version of the Quality of Life in Childhood Epilepsy Questionnaire-16-C (QOLCE-16-C): Translation, validity, and reliability. Health Qual. Life Outcomes 20:52. doi: 10.1186/s12955-022-01960-8

PubMed Abstract | Crossref Full Text | Google Scholar

Tassinari, C. A., and Rubboli, G. (2006). Cognition and paroxysmal EEG activities: From a single spike to electrical status epilepticus during sleep. Epilepsia 47(Suppl. 2), 40–43. doi: 10.1111/j.1528-1167.2006.00686.x

PubMed Abstract | Crossref Full Text | Google Scholar

Taylor, I., Berkovic, S. F., Kivity, S., and Scheffer, I. E. (2008). Benign occipital epilepsies of childhood: Clinical features and genetics. Brain 131(Pt 9), 2287–2294. doi: 10.1093/brain/awn138

PubMed Abstract | Crossref Full Text | Google Scholar

Tononi, G., and Cirelli, C. (2003). Sleep and synaptic homeostasis: A hypothesis. Brain Res. Bull. 62, 143–150. doi: 10.1016/j.brainresbull.2003.09.004

PubMed Abstract | Crossref Full Text | Google Scholar

Vears, D. F., Tsai, M. H., Sadleir, L. G., Grinton, B. E., Lillywhite, L. M., Carney, P. W., et al. (2012). Clinical genetic studies in benign childhood epilepsy with centrotemporal spikes. Epilepsia 53, 319–324. doi: 10.1111/j.1528-1167.2011.03368.x

PubMed Abstract | Crossref Full Text | Google Scholar

Wirrell, E. C., Grossardt, B. R., Wong-Kisiel, L. C., and Nickels, K. C. (2011). Incidence and classification of new-onset epilepsy and epilepsy syndromes in children in Olmsted County, Minnesota from 1980 to 2004: A population-based study. Epilepsy Res. 95, 110–118. doi: 10.1016/j.eplepsyres.2011.03.009

PubMed Abstract | Crossref Full Text | Google Scholar

Wu, H. Y., Wang, Y., and Han, W. (2015). Effects of acupuncture stimulation on dynamic changes of cerebral TNF-α and C-reaction protein levels in cerebral ischemia-reperfusion rats. Zhen Ci Yan Jiu 40, 215–218.

Google Scholar

Wu, R., Ma, H., Hu, J., Wang, D., Wang, F., Yu, X., et al. (2024). Electroacupuncture stimulation to modulate neural oscillations in promoting neurological rehabilitation. Brain Res. 1822:148642. doi: 10.1016/j.brainres.2023.148642

PubMed Abstract | Crossref Full Text | Google Scholar

Yi, P. L., Lu, C. Y., Jou, S. B., and Chang, F. C. (2015). Low-frequency electroacupuncture suppresses focal epilepsy and improves epilepsy-induced sleep disruptions. J. Biomed. Sci. 22:49. doi: 10.1186/s12929-015-0145-z

PubMed Abstract | Crossref Full Text | Google Scholar

Zhang, R., Lao, L., Ren, K., and Berman, B. M. (2014). Mechanisms of acupuncture-electroacupuncture on persistent pain. Anesthesiology 120, 482–503. doi: 10.1097/ALN.0000000000000101

PubMed Abstract | Crossref Full Text | Google Scholar

Keywords: benign epilepsy of childhood with central temporal spikes (BECTS), traditional Chinese medicine (TCM), snap-needle, acupuncture, case report

Citation: Shi J, Gong Y, Deng Y, Ma Z, Xiao Z, Tan H and Qin W (2025) Efficacy of snap-needle patch therapy in pediatric epilepsy: a case study. Front. Hum. Neurosci. 19:1618266. doi: 10.3389/fnhum.2025.1618266

Received: 29 April 2025; Accepted: 25 September 2025;
Published: 10 October 2025.

Edited by:

Rana Mumtaz Raoof, University of Mosul, Iraq

Reviewed by:

Georgios Mikellides, University of Nicosia, Cyprus
Xuetong Zhai, University of Pittsburgh, United States

Copyright © 2025 Shi, Gong, Deng, Ma, Xiao, Tan and Qin. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: WeiLan Qin, V2xxaW5AcXEuY29t

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.